2022 ACNP President's Letter, Carlos A. Zarate, Jr., M.D.

Click here to read the 2022 President's Letter.

Compulsivity and impulsivity

Neuropsychopharmacology Editor's Choice

Volume 47, Issue 2 (January 2022)

Highlighting Research on Health Disparities

New Neuropsychopharmacology Collection

View Now

Effects of post-partum scarcity on maternal behavior

Neuropsychopharmacology Editor's Choice

Volume 47, Issue 2 (January 2022)

Congratulations to the 2022 Associate Members, Members, and Fellows!

Click here to view the 2022 new members!

Review: Neuroimaging and sex differences

Neuropsychopharmacology Editor's Choice

Volume 47, Issue 2 (January 2022)

61st Annual Meeting

Dec 4-7, 2022

Phoenix, Arizona
More Annual Meeting Info

Deadlines

Meeting Evaluation & CME Credits

January 19, 2022

ACNP/AMP BRAD Application

June 1, 2022

Digital Library Resources

Go to the Digital Library

Neuro News

Fluvoxamine for COVID?

A widely prescribed SSRI antidepressant may have anti-inflammatory properties beneficial in the treatment of COVID. (Article - VOX)

Read More

Twitter

Registration

Plans for the 60th Annual Meeting are underway in a hybrid meeting format (both in person and virtually).
Program

The Annual Meeting Program is available to access the agenda for the 60th Annual Meeting.

Travel Award

ACNP annually selects distinguished young scientists to be a part of an outstanding scientific program in clinical and basic research.

ACNP is a non-profit, professional society dedicated to advancing the scientific understanding of and facilitating communication about disorders of the brain and behavior in order to advance their prevention and treatment.